Skip to main content

Efficient Production of Human Norovirus-Specific IgY in Egg Yolks by Vaccination of Hens with a Recombinant Vesicular Stomatitis Virus Expressing VP1 Protein.

Human norovirus (HuNoV) is responsible for over 95% of outbreaks of acute nonbacterial gastroenteritis worldwide. Despite great efforts, there is no vaccine or effective therapeutic intervention against this virus. Chicken immunoglobulin Y (IgY) based passive immunization has proven to be an effective strategy for preventing and treating many diseases enteric viruses.

Here, we develop highly efficient bioreactor Parasite Recombinant Proteins to produce high titers of specific HuNoV yellow chicken IgY in using recombinant vesicular stomatitis virus expressing HuNoV capsid protein (rVSV-VP1) as antigen. We first show that HuNoV VP1 protein is highly expressed in chicken cells infected with rVSV-VP1. 

Furthermore, we find that the White Leghorn chickens were immunized intramuscularly with rVSV-VP1 high level trigger specific HuNoV yolk antibody IgY. yellow efficiently purified IgY recognized by HuNoV virus-like particle (VLP). Importantly, specific IgY efficient HuNoV HuNoV blocked VLP binding to all three types (A, B, and O) histo-blood group antigens (HBGAs), factors of attachment to HuNoV.

 In addition, the receptor blocking activity of IgY remain stable at temperatures below 70 ° C and at a pH range from 4 to 9. Thus, the chickens immunized with VSV-VP1 can be cost-effective and practical strategies for large-scale production of antibody IgY-HuNoV anti for potential use as a prophylactic treatment and therapy against infections HuNoV.
Efficient Production of Human Norovirus-Specific IgY in Egg Yolks by Vaccination of Hens with a Recombinant Vesicular Stomatitis Virus Expressing VP1 Protein.

Generation and evaluation of goose origin expressing recombinant Newcastle disease virus proteins Cap avastrovirus goose origin as a bivalent vaccine in goslings.


Currently, the two geese astrovirus (GoAstV) and goose-origin Newcastle disease virus (NDV) widespread infectious agent for the goose. There is no vaccine for GoAstV. Capsid proteins can induce neutralizing antibodies human astroviruses (HAstV). molecular analysis of genomic region encoding the capsid protein (ORF2) of geese astrovirus has revealed that it contains a neutralization epitope. Goose-origin NDV is also an infectious agent.

 Various existing NDV strains which can be commonly used as a vaccine vector. In this study, a fusion protein cleavage site in the F ↓ RRQKR backbone of goose-origin virulent NDV SH-12 is converted into motive GRQGR avirulent L. ↓ goose-origin modified NDV expressing recombinant vaccine virus capsid protein (Cap) of GoAstV generated as bivalent vaccine using reverse-genetics approach. 

Recombinant virus, rNDV / GoAstV-Cap, the attenuated Purified Recombinant Proteins and the same growth dynamics, cytopathic effects, and viral titers in vitro preserved when compared with the Lasota strain. GoAstV-Cap protein expression in rNDV / GoAstV-Cap-infected cells was detected by immunofluorescence assay and Western blotting. Goslings inoculated with rNDV / GoAstV-Cap showed obvious signs of disease and causes the immune response and serum antibody responses to NDV-specific GoAstV-Cap-specific vaccination to control Lasota.
Labels:

Comments

Post a Comment

Popular posts from this blog

Development of an enzyme-linked immunosorbent assay using recombinant protein antigen for the diagnosis of Chikungunya virus.

We describe here the development of in-house enzyme linked immunosorbent assay (ELISA) for diagnostic Chikungunya virus (CHIKV) infection using a recombinant protein of CHIKV. Recombinant protein gene was designed based on 154 sequences and we used computational methods to predict the structure and antigenic potential.  For the prediction of confirmation, the Monkey Recombinant Proteins  gene coding for a recombinant protein CHIKV (rCHIKVp) has been synthesized and expressed in a prokaryotic system. Subsequently, the protein was purified by affinity chromatography and used as an antigen in an indirect ELISA. We present data on production optimization and preparation of the recombinant antigen ELISA to detect IgG against CHIKV in human sera. Development of an enzyme-linked immunosorbent assay for viral infections in horses latex using recombinant E2 protein as an antigen. Gum virus causes fever, skin eruptions, and limb edema in horses. For high-throughput and time-saving method for se
Post a Comment
Read more

Optimization of recombinant Zika virus NS1 protein secretion from HEK293 cells.

Sensitive, accurate and cost-effective diagnostic tests are needed to detect the Zika virus (ZIKV) infection. Nonstructural 1 (NS1) glycoprotein is an excellent diagnostic marker because it was released in a hexameric conformation of the infected cells into the bloodstream of patients in the early course of infection.  We established a stable system Fungal Recombinant Proteins  of his rZNS1-expression in HEK293 cells through lentiviral transduction. New optimization approach to improve his rZNS1 secretion of proteins in mammalian expression systems is achieved through incubation of 50 nM rapamycin followed by incubation in serum-free media for 9 days, attaining the protein from ~ 10 mg / l of culture medium.  His rZNS1 purified hexamer recognized by anti-NS1 antibodies in serum ZIKV patients, and demonstrated the ability to induce a humoral response in mice immunized. recombinant proteins obtained are reliable biological tool that can potentially be applied in the development of diagn
Post a Comment
Read more

Recombinant Lactococcus Lactis Expressing M1-HA2 Fusion Protein Provides Protective Mucosal Immunity Against H9N2 Avian Influenza Virus in Chickens.

H9N2 subtype avian influenza virus of low pathogenicity (LPAIV) are distributed worldwide and cause enormous economic losses in the poultry industry. Although almost all the chickens immunized with the inactivated vaccine, the disease is still widespread. We speculate that increase mucosal or cellular immune response may contribute to improving the H9N2 virus surveillance.  In this study, we Bovine Recombinant Proteins  constructed a novel Lactococcus lactis (L. lactis) strain expressing a recombinant fusion protein consisting of the M1 and HA2 proteins derived from the H9N2 viral strain endemic conserved antigens. M1-HA2 fusion protein was cloned downstream of the gene encoding the secretory peptide, and we subsequently confirmed that the fusion protein is secreted from L.  lactis by Western blotting. We assess the immunogenicity and protective effects of recombinant L. lactis this tension. Eight chicken 1-day-old were divided into four groups, and the experimental group orally vacci
Post a Comment
Read more